SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-015491
Filing Date
2018-11-13
Accepted
2018-11-13 16:04:07
Documents
86
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0918_immucellcorp.htm 10-Q 569227
2 CERTIFICATION f10q0918ex31_immucell.htm EX-31 6878
3 CERTIFICATION f10q0918ex32_immucell.htm EX-32 4368
  Complete submission text file 0001213900-18-015491.txt   4905961

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE iccc-20180930.xml EX-101.INS 982401
5 XBRL SCHEMA FILE iccc-20180930.xsd EX-101.SCH 55054
6 XBRL CALCULATION FILE iccc-20180930_cal.xml EX-101.CAL 58687
7 XBRL DEFINITION FILE iccc-20180930_def.xml EX-101.DEF 165950
8 XBRL LABEL FILE iccc-20180930_lab.xml EX-101.LAB 505352
9 XBRL PRESENTATION FILE iccc-20180930_pre.xml EX-101.PRE 341330
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 181177898
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Assistant Director 1